AMI Clinical Trials

727 recruitingLast updated: July 25, 2026

There are 727 actively recruiting ami clinical trials across 75 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include Beijing, Beijing Municipality, China, New York, New York, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


AMI Trials at a Glance

727 actively recruiting trials for ami are listed on ClinicalTrialsFinder across 6 cities in 75 countries. The largest study group is Not Applicable with 309 trials, with the heaviest enrollment activity in Beijing, New York, and Boston. Lead sponsors running ami studies include Cairo University, Peking University First Hospital, and Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

Treatments under study

About AMI Clinical Trials

Looking for clinical trials for AMI? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new AMI trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about AMI clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 727 trials

Recruiting

Natural History Study of Patients With Excess Androgen

Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3,000 enrolled2 locationsNCT00250159
Recruiting
Not Applicable

Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery

Acute Kidney InjuryCardiac Surgeryhemodynamic stability+1 more
Hospices Civils de Lyon40 enrolled2 locationsNCT06251713
Recruiting

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

Renal Cell CarcinomaKidney CancerClear Cell Renal Cancer+2 more
National Cancer Institute (NCI)5,000 enrolled1 locationNCT00001238
Recruiting
Phase 1

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

HypercholesterolaemiaMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG90 enrolled19 locationsNCT07491172
Recruiting

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

Genetic diseasesFeverROSAH+4 more
National Human Genome Research Institute (NHGRI)5,000 enrolled5 locationsNCT00001373
Recruiting
Phase 3

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia - Homozygous
Novartis Pharmaceuticals9 enrolled19 locationsNCT06597006
Recruiting
Phase 1Phase 2

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Colorectal, CancerProstate CancerCancer+12 more
Parabilis Medicines, Inc.619 enrolled33 locationsNCT05919264
Recruiting
Not Applicable

Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)

Familial Adenomatous Polyposis (FAP)Pouches, Ileoanal
London North West Healthcare NHS Trust50 enrolled1 locationNCT07726771
Recruiting
Not Applicable

GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes

Type 1 Diabetes Mellitus (T1DM)Hypoglycemia (Diabetic)Diabetes Distress+1 more
Shifa International Hospital110 enrolled1 locationNCT07726680
Recruiting
Phase 1

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Inherited Bone Marrow Failure SyndromeFamilial Platelet Disorder With Predisposition to Myeloid Malignancies
National Cancer Institute (NCI)75 enrolled1 locationNCT06090669
Recruiting

Natural History of Depression, Bipolar Disorder and Suicide Risk

Molecular Mechanisms of Pharmacological ActionDepressive SymptomsSuicide+18 more
National Institute of Mental Health (NIMH)500 enrolled1 locationNCT06462196
Recruiting

A Natural History Study of Bone and Mineral Disorders

Tumor Induced OsteomalciaOsteomalaciaFamilial Tumoral Calcinosis
National Institute of Dental and Craniofacial Research (NIDCR)1,000 enrolled1 locationNCT00024804
Recruiting
Not Applicable

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

Heart FailureCardiogenic ShockAcute Myocardial Infarction (AMI)
Magenta Medical Ltd.10 enrolled8 locationsNCT07293923
Recruiting
Phase 3

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Familial Partial Lipodystrophy
Chiesi Farmaceutici S.p.A.24 enrolled7 locationsNCT06679270
Recruiting

Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START

Rural HealthSubstance Use Disorder (SUD)Child Maltreatment+3 more
Ohio State University400 enrolled1 locationNCT07278427
Recruiting
Phase 2

Role of Estrogen on Skeletal Outcomes in FHA

Bone DensityFHA (Functional Hypothalamic Amenorrhea)Bone Strength
University of Virginia150 enrolled2 locationsNCT07010146
Recruiting
Phase 2

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

GerminomaBasal Ganglia GerminomaDiabetes Insipidus+3 more
Children's Oncology Group240 enrolled114 locationsNCT06368817
Recruiting

Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure

Vitamin K-Dependent Coagulation DefectSignificant Bleeding Risk
Octapharma3,574 enrolled1 locationNCT06429787
Recruiting
Not Applicable

text4FATHER R21: Social Media - Efficacy Trial

FathersMobile HealthNuclear Family
Johns Hopkins University180 enrolled1 locationNCT06289101
Recruiting

A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

Cardiovascular DiseasesAtherosclerotic Cardiovascular DiseaseHypercholesterolemia, Familial
Novartis Pharmaceuticals5,995 enrolled1 locationNCT07543731